Purple Biotech (PPBT) Competitors $2.49 +0.09 (+3.92%) Closing price 07/3/2025 03:44 PM EasternExtended Trading$2.41 -0.08 (-3.33%) As of 07/3/2025 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PPBT vs. MTVA, TRIB, ATHA, BGXX, BCDA, EQ, SNSE, LPTX, BTAI, and XFORShould you be buying Purple Biotech stock or one of its competitors? The main competitors of Purple Biotech include MetaVia (MTVA), Trinity Biotech (TRIB), Athira Pharma (ATHA), Bright Green (BGXX), BioCardia (BCDA), Equillium (EQ), Sensei Biotherapeutics (SNSE), Leap Therapeutics (LPTX), BioXcel Therapeutics (BTAI), and X4 Pharmaceuticals (XFOR). These companies are all part of the "pharmaceutical products" industry. Purple Biotech vs. Its Competitors MetaVia Trinity Biotech Athira Pharma Bright Green BioCardia Equillium Sensei Biotherapeutics Leap Therapeutics BioXcel Therapeutics X4 Pharmaceuticals Purple Biotech (NASDAQ:PPBT) and MetaVia (NASDAQ:MTVA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, media sentiment, risk, institutional ownership and dividends. Do institutionals & insiders believe in PPBT or MTVA? 9.6% of Purple Biotech shares are held by institutional investors. Comparatively, 1.4% of MetaVia shares are held by institutional investors. 3.0% of Purple Biotech shares are held by company insiders. Comparatively, 0.8% of MetaVia shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is PPBT or MTVA more profitable? Purple Biotech's return on equity of -17.84% beat MetaVia's return on equity.Company Net Margins Return on Equity Return on Assets Purple BiotechN/A -17.84% -15.44% MetaVia N/A -222.13%-123.85% Which has more risk & volatility, PPBT or MTVA? Purple Biotech has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500. Comparatively, MetaVia has a beta of 0.21, indicating that its share price is 79% less volatile than the S&P 500. Which has higher valuation and earnings, PPBT or MTVA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPurple BiotechN/AN/A-$7.24M-$2.62-0.95MetaViaN/AN/A-$27.59MN/AN/A Does the media favor PPBT or MTVA? In the previous week, Purple Biotech's average media sentiment score of 0.00 equaled MetaVia'saverage media sentiment score. Company Overall Sentiment Purple Biotech Neutral MetaVia Neutral Do analysts recommend PPBT or MTVA? Purple Biotech currently has a consensus target price of $33.00, indicating a potential upside of 1,223.18%. MetaVia has a consensus target price of $7.50, indicating a potential upside of 1,057.59%. Given Purple Biotech's higher probable upside, equities research analysts plainly believe Purple Biotech is more favorable than MetaVia.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Purple Biotech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00MetaVia 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryPurple Biotech beats MetaVia on 7 of the 8 factors compared between the two stocks. Get Purple Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PPBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PPBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PPBT vs. The Competition Export to ExcelMetricPurple BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.30M$2.91B$5.55B$9.04BDividend YieldN/A2.44%5.22%3.99%P/E Ratio-0.9521.5627.6620.24Price / SalesN/A281.56418.72118.54Price / CashN/A42.7336.8958.10Price / Book0.107.518.035.67Net Income-$7.24M-$55.14M$3.18B$249.21M7 Day Performance5.28%4.61%2.93%3.28%1 Month Performance-4.81%0.90%1.72%3.95%1 Year PerformanceN/A5.40%34.39%20.98% Purple Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PPBTPurple Biotech2.4172 of 5 stars$2.49+3.9%$33.00+1,223.2%N/A$3.30MN/A-0.9520Gap UpMTVAMetaViaN/A$0.64+2.1%$7.50+1,066.0%N/A$12.34MN/A0.008Gap DownTRIBTrinity Biotech0.3735 of 5 stars$0.65-0.3%N/A-65.3%$11.77M$61.56M-0.23480News CoverageGap UpATHAAthira Pharma2.7377 of 5 stars$0.30+2.4%$11.25+3,625.2%-87.0%$11.52MN/A-0.1540Gap DownBGXXBright GreenN/AN/AN/AN/A$11.47MN/A-1.002Gap DownBCDABioCardia3.9871 of 5 stars$1.95-9.3%$25.00+1,182.1%-29.0%$11.13M$60K-0.8440News CoverageInsider TradeEQEquillium1.8169 of 5 stars$0.32+1.7%$3.00+851.8%-51.9%$11.07M$41.10M-0.8140Gap UpSNSESensei Biotherapeutics4.1992 of 5 stars$8.58-1.2%$90.00+949.0%-27.1%$10.94MN/A-0.3740Gap DownLPTXLeap Therapeutics1.4188 of 5 stars$0.30+13.5%$3.38+1,036.7%-85.6%$10.84MN/A-0.1740News CoverageBTAIBioXcel Therapeutics4.5038 of 5 stars$1.81+2.3%$42.60+2,253.6%-88.3%$10.72M$2.27M-0.1390Gap UpXFORX4 Pharmaceuticals4.6695 of 5 stars$1.90+3.8%$72.33+3,707.0%-88.1%$10.59M$2.56M0.8980News CoverageHigh Trading Volume Related Companies and Tools Related Companies MetaVia Competitors Trinity Biotech Competitors Athira Pharma Competitors Bright Green Competitors BioCardia Competitors Equillium Competitors Sensei Biotherapeutics Competitors Leap Therapeutics Competitors BioXcel Therapeutics Competitors X4 Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PPBT) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PPBT Stock Alerts